Global Biological Drugs Market Sales, Market Overview, Analysis Research Report 2023

1
(No Transcript)
2
Biological Drugs Market Global Industry
Analysis, Trends, Market Size Forecasts up to
2023
A latest report has been added to the wide
database of Biological Drug Market by Infinium
Global Research. This report studies the
Diabetes Drug Therapy Market by Product Type
(therapeutic protein -levemir, neulasta, eylea,
novolog, enbrel, avonex, neupogen, humalog,
victoza, lantus, epogen, aranesp monoclonal
antibody - avastin, humira, remicade vaccine -
gardasil, prenvar 13, fluzone) market status and
outlook of global and major regions, from
manufacturers, and end industries. The objective
of the study is to identify market sizes of
different segments countries in recent years
and to forecast the values for the next six
years. Diabetes Drug Therapy Market provides
opportunities in micro markets for stakeholders
to invest along with the detailed analysis of
competitive landscape, latest trends, and
product offerings of the major companies in the
Diabetes Drug Therapy Market. According to the
report the Global Biological Drugs Market is
projected to grow at a CAGR between 10.0 to
10.5 in terms of value over the period of
2017-2023. Increasing geriatric population in
the world is driving the growth of the biological
drugs market, as there is increasing requirement
for effective medicines for various illnesses
affecting old age people. Increasing number of
patients with cancer, diabetes and other major
chronic illnesses are expected to drive the
growth of the biological drugs market during the
forecast period. Biological drugs are more
effective than respective chemical and other
alternative medicines for several complex chronic
illnesses. Hence, the biological drugs market is
anticipated to attain significant growth in
demand, despite the high cost of the products.
The investments in research and development of
biological drugs and innovation in manufacturing
of biologics are anticipated to yield more
products during the forecast period. Moreover,
the promotional activities by various health
organisations and policies by governments to make
biological drugs affordable for the treatment of
chronic illnesses are expected to enhance the
growth of the global biological drugs market.
Furthermore, the health regulatory policies with
restrictions on chemical drugs with severe side
effects and the improving healthcare services in
various countries are expected to enhance the
growth of the global biological drugs
market. The expiry of patents of many biological
drugs provides opportunity for low cost
biosimilars and other biological pharmaceutical
companies to manufacture alternative drugs.
Higher cost of manufacturing and the higher
selling price of biological drugs give
biosimilars and other alternatives the price
advantage. Severe side effects related to
injectable type of biological drugs is a
restraint to the expansion of the market. The
complexity of manufacturing of biological drugs
is a major challenge for the global biological
manufacturers, especially in the developing and
least developed countries, where it is difficult
to maintain both the controlled environment for
manufacturing and quality control. Moreover,
lack of proper refrigeration or environment
controllable transportation facilities hinder the
uniform quality of biological drugs in different
regions, due to contamination at different
stages. However, the need for effective medicines
for illnesses like cancer,
3
autoimmune diseases, and other chronic illnesses
with minimal side effects when compared to
chemical drugs is expected to provide
opportunities for major players in the biological
drugs market during the forecast
period. Segments Covered The report segments
the global biological drugs market by product and
region. On the basis of product, the market is
segmented as protein therapy, mAb therapy and
vaccines. Monoclonal antibodies segment is
expected to sustain a major share in the global
biological drugs market during the forecast
period. Among protein therapy segment, Enbrel is
expected to attain more demand with fastest
growth rate during the forecast period. Among
the vaccines, the demand for Prevnar 13 is
anticipated to grow significantly during the
forecast period. Geographic Coverage and
Analysis The report provides regional analysis
covering geographies such as North America,
Europe, Asia-Pacific, and Rest of the World.
North America dominates the global biological
drugs market with a major share. Increasing
technological advancements, favorable regulatory
policies and increasing awareness about the
biological due to intervention of governments and
other agencies are the major factors that drive
the growth of the North American biological drugs
market. Moreover, the increasing demand for
biological drugs for the treatment of chronic
illnesses such as cancer and diabetes is
anticipated to drive the growth of the North
American biological market during the forecast
period. The presence of large geriatric
population in the countries such as Germany and
United Kingdom drive the growth of European
biological drugs market. Furthermore, presence of
top quality research and development
infrastructure due to the partnerships between
research institutes and manufacturing companies
and increased funding from private-public
initiatives drives the growth of the European
market. The demand for alternative drugs for the
treatment of chronic illnesses from the emerging
nations in the Eastern Europe is anticipated to
enhance the growth of the European biological
drugs market. Presence of large population with
chronic illnesses, initiatives from governments
to promote biologics, high investments in
biologic drug manufacturing facilities,
encouragement for biotech companies and research
initiatives are major factors that drive the
Asian biological drugs market. Moreover, the low
manufacturing cost and the availability of low
cost labor is expected to enhance the growth of
the Asian biological drugs market, as it could
attract more established players in the global
market to Asia. The presence of good regulatory
frameworks for biologics, increasing instances of
chronical illnesses and encouragement from
governments to promote manufacturing of drugs to
in the region to make treatments affordable are
the major factors that drive the Latin American
biological drugs market. Substandard biological
drugs due to the absence of stringent regulatory
frameworks, presence of biosimilars and other
alternatives are the major restraints for
African biological drugs market. However, with
the Ebola outbreak in recent past and the
presence of large number of patients with AIDS
and other chronic illnesses provide positive
outlook for the growth of the biological drugs
market in Africa. Presence of
4
numerous patients with diabetes, rheumatoid
arthritis and other chronic illnesses and
availability of good healthcare systems are
expected to drive the biological drugs market in
the Middle East during the forecast
period. Companies Profiled

AbbVieInc, Amgen Inc, Bristol-Myers Squibb,
Biogen Idec, Hoffman-La Roche AG, Johnson
Johnson, Lilly, Merck Co Inc, Novartis , Novo
Nordisk , Pfizer Inc, Sanofi SA.
Click the Below Full Report Link-
https//www.infiniumglobalresearch.com/healthcare_
medical_devices/biological_drugs_market Report
Highlights The report provides deep insights on
demand forecasts, market trends and micro and
macro indicators. In addition, this report
provides insights on the factors that are
driving and restraining the demand of biological
drugs globally as well as regionally. Moreover,
IGR-Growth Matrix analysis given in the report
brings an insight on the investment areas that
existing or new market players can consider. The
report provides insights into the market using
analytical tools such as Porters five forces
analysis and value chain analysis of biological
drugs. Moreover, the study highlights current
market trends and provides forecast from 2017 to
2023. We also have highlighted future trends in
the biological drugs market that will impact the
demand during the forecast period. Moreover, the
competitive analysis given in each regional
market brings an insight on the market share of
the leading players. Additionally, the analysis
highlights rise and fall in the market shares of
the key players in the market. This report will
help manufacturers, suppliers and distributors of
the biological drugs market to understand the
present and future trends in this market and
formulate their strategies accordingly.
5
About Us Infinium Global Research and Consulting
Solutions are started with a single motto of
being business partner of first choice. We at
Infinium work on the strengths of our clients to
ensure we help them consolidate their market
position. We firmly believe in the fact that if
you are able to develop newer opportunities then
you find there is no dearth of opportunities for
you. With our strategic research approaches and
deep dive in the market segments, we try to find
out new opportunities that our clients can encash
with their existing resources. Our experts with
over 100 years of cumulative experience in
research offer the best in the industry services
to our clients to ensure that they achieve their
business goals. Browse Detailed TOC, Description
and Companies Mentioned in Report _at_
https//www.infiniumglobalresearch.com/healthcare_
medical_devices/biological_drugs_market